COLLAGEN Solutions, which manufactures medical-grade collagen products in Glasgow, has been selected to take part in a European research project aimed at developing novel treatments for Parkinson’s disease.
The Alternative Investment Market-listed company said that it would, as a key member of the research consortium, “receive significant funding to develop various types of medical-grade collagens for investigation” over the duration of the project.
Shares in Collagen Solutions, which has a 6,500 sq ft manufacturing operation at the former Devro collagen-making site on the edge of Glasgow, rose by 0.5p or 4.5 per cent to 11.5p.
The research project is being led by CURAM, the Centre for Research in Medical Devices based at the National University of Ireland Galway, which has secured €4 million (£2.9m) in funding through the European Horizon 2020 grant programme.
The project is entitled ‘Development of biomaterial-based delivery systems for Parkinson’s disease - an integrated pan-European approach’.
Collagen Solutions said that the project was aimed at facilitating collaboration between world-class researchers and industry partners to develop the first disease-modifying therapy for Parkinson’s, which could “slow down the progression of the disease rather than offering mere symptomatic benefits”.
Stewart White, chief executive officer of Collagen Solutions, said: “Collagen Solutions is delighted to be part of such an esteemed consortium working on developing new therapies for such a devastating condition.
“I believe our shared success as part of the consortium provides further validation of the company’s reputation for developing…consistent high-quality, medical-grade collagen products for its international clients. Our R&D (research and development) capabilities, global reach, and state-of-the-art manufacturing facilities in Scotland and New Zealand make us an obvious partner for this exciting project.”
CURAM director Abhay Pandit said: “Collagen Solutions’ ability to source, develop and manufacture collagen components for therapeutic use will be critical in meeting the requirements for a functional delivery formulation for the project.
“It is a mark of quality for all involved to have secured this grant funding, and we are very pleased to welcome Collagen Solutions to the consortium.”
Why are you making commenting on The Herald only available to subscribers?
It should have been a safe space for informed debate, somewhere for readers to discuss issues around the biggest stories of the day, but all too often the below the line comments on most websites have become bogged down by off-topic discussions and abuse.
heraldscotland.com is tackling this problem by allowing only subscribers to comment.
We are doing this to improve the experience for our loyal readers and we believe it will reduce the ability of trolls and troublemakers, who occasionally find their way onto our site, to abuse our journalists and readers. We also hope it will help the comments section fulfil its promise as a part of Scotland's conversation with itself.
We are lucky at The Herald. We are read by an informed, educated readership who can add their knowledge and insights to our stories.
That is invaluable.
We are making the subscriber-only change to support our valued readers, who tell us they don't want the site cluttered up with irrelevant comments, untruths and abuse.
In the past, the journalist’s job was to collect and distribute information to the audience. Technology means that readers can shape a discussion. We look forward to hearing from you on heraldscotland.com
Comments & Moderation
Readers’ comments: You are personally liable for the content of any comments you upload to this website, so please act responsibly. We do not pre-moderate or monitor readers’ comments appearing on our websites, but we do post-moderate in response to complaints we receive or otherwise when a potential problem comes to our attention. You can make a complaint by using the ‘report this post’ link . We may then apply our discretion under the user terms to amend or delete comments.
Post moderation is undertaken full-time 9am-6pm on weekdays, and on a part-time basis outwith those hours.
Read the rules here